게시판

[ 2025년 9월 12일: Gastric Cancer 논문게재승인 ] 

Re.: Ms. No. GCAN-D-25-00354R2

Title: Development of adenovirus-based oncolytic virus to induce EBV lytic reactivation. 

We are pleased to tell you that your work has now been accepted for publication in Gastric Cancer. The files uploaded to Editorial Manager will be used as they are for production. You will receive emails from Springer Nature in due course regarding the publishing process. If you have any queries, please contact us via "Contact Us". Please remember to quote the manuscript number, GCAN-D-25-00354R2, whenever inquiring about your manuscript. Thank you for submitting your work to this journal. With kind regards.                                      

Yasuhiro Kodera, Editor-in-Chief, Gastric Cancer

[ 2025년 5월 24일: IHW 2025 구두 및 포스터 발표승인 ] 

IHW 2025: Submission Status

Dear Hyojeung Kang, Congratulations! Your abstract submission 406 - “Novel Adenovirus-Based Oncolytic Approaches for Stimulating EBV Lytic Replication”, has been accepted for both an oral and poster presentation at the 49th International Herpesvirus Workshop 2025, which will take place at the Estrel Congress Center in Berlin, Germany on 26–30 July 2025. While we are looking forward to your oral presentation at the Workshop, we are unable to offer you a Travel Award at this time due to current funding limitations. That said, if additional funding becomes available, we will revisit pending applications and notify you if your status changes.

Oral Presentation Session: Concurrent Session 3B: Latency and Reactivation 1, Session Date/time: 7/29/2025 - 11:00 AM - 12:30 PM

Poster Presentation Sessions: You will present your poster at one of the following sessions. Poster sessions are scheduled based on topic and the last two digits of your poster number. You will receive your poster number assignment in mid-June. Poster Session 01: Sunday, 27 July: 19:00 – 22:00, Poster Session 02: Tuesday, 29 July: 19:00 – 22:00

Thank you, IHW 2025 Secretariat, On behalf of the 2025 IHW Co-chairs ,Email: IHW@ConferenceSolutionsInc.com, Phone: +1.503.244.4294 ext. 1010

[ 2025년 5월 22일: Gastric Cancer 논문게재승인 ] 

Re.: Ms. No. GCAN-D-25-00048R3

Title: Dihydrotestosterone-Androgen Receptor Signaling Suppresses EBV-Positive Gastric Cancer through DNA Demethylation-Mediated Viral Reactivation. 

We are pleased to tell you that your work has now been accepted for publication in Gastric Cancer. The files uploaded to Editorial Manager will be used as they are for production. You will receive emails from Springer Nature in due course regarding the publishing process. If you have any queries, please contact us via "Contact Us". Please remember to quote the manuscript number, GCAN-D-25-00048R3, whenever inquiring about your manuscript. Thank you for submitting your work to this journal. With kind regards.                                      

Yasuhiro Kodera, Editor-in-Chief, Gastric Cancer

[ 2025년 5월 19일: IJMS 논문게재승인 ] 

[IJMS] Manuscript ID: ijms-3603533 - Accepted for Publication

Dear Professor Kang, Professor Cho, Congratulations on the acceptance of your manuscript, and thank you for submitting your work to IJMS:

Manuscript ID: ijms-3603533, Type of manuscript: Article, Title: Inhibition of MCP1 (CCL2) enhances antitumor activity of NK cells against HCC cells under hypoxia, Authors: Hwan Hee Lee, Juhui Kim, Eunbi Park, Hyojeung Kang *, Hyosun Cho *, Received: 8 Apr 2025, Kind regards,

Maurizio Battino, Editor-in-Chief

[ 2025년 5월 13일: 변혜지학생 포스터상 수상 ]

[대한약학회] 2025 춘계국제학술대회 포스터상 수상자 발표 

1. 회원 여러분의 건승을 기원합니다.

2. 2025 춘계국제학술대회에서 발표된 포스터 논문에 대해, 각 분과학회 학술위원과 집행부 학술위원회의 심사를 거쳐 포스터상 수상자를 다음과 같이 선정하였음을 알려드립니다.

발표번호: P5-12, 발표자: 변혜지 , 소속: 경북대학교 약학대학, 제목: Development of gene therapeutics using oncolytic adenovirus to disrupt EBV latency in cancer